NovoCure Ltd — Director's Dealing 2015

Oct 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-02

Reporting Person: Ambrogi Michael J. (Cheif Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-02	Options to Buy Ordinary Shares	$22.00	A	147825	Acquired	2025-10-02	Ordinary Shares (147825)	Direct

Footnotes

F1: Options to buy 147,825 ordinary shares were granted contingent upon the consummation of the registrant's initial public offering and will vest and become exercisable in equal installments on each of October 2, 2016, 2017, 2018 and 2019, subject to Mr. Ambrogi's continued employment through such dates.